20937119|t|Attenuation of circulatory shock and cerebral ischemia injury in heat stroke by combination treatment with dexamethasone and hydroxyethyl starch.
20937119|a|BACKGROUND: Increased systemic cytokines and elevated brain levels of monoamines, and hydroxyl radical productions are thought to aggravate the conditions of cerebral ischemia and neuronal damage during heat stroke. Dexamethasone (DXM) is a known immunosuppressive drug used in controlling inflammation, and hydroxyethyl starch (HES) is used as a volume-expanding drug in cerebral ischemia and/or cerebral injury. Acute treatment with a combined therapeutic approach has been repeatedly advocated in cerebral ischemia experiments. The aim of this study is to investigate whether the combined agent (HES and DXM) has beneficial efficacy to improve the survival time (ST) and heat stroke-induced cerebral ischemia and neuronal damage in experimental heat stroke. METHODS: Urethane-anesthetized rats underwent instrumentation for the measurement of colonic temperature, mean arterial pressure (MAP), local striatal cerebral blood flow (CBF), heart rate, and neuronal damage score. The rats were exposed to an ambient temperature (43 degrees centigrade) to induce heat stroke. Concentrations of the ischemic and damage markers, dopamine, serotonin, and hydroxyl radical productions in corpus striatum, and the serum levels of interleukin-1 beta, tumor necrosis factor-alpha and malondialdehyde (MDA) were observed during heat stroke. RESULTS: After heat stroke, the rats displayed circulatory shock (arterial hypotension), decreased CBF, increased the serum levels of cytokines and MDA, increased cerebral striatal monoamines and hydroxyl radical productions release, and severe cerebral ischemia and neuronal damage compared with those of normothermic control rats. However, immediate treatment with the combined agent at the onset of heat stroke confers significant protection against heat stroke-induced circulatory shock, systemic inflammation; cerebral ischemia, cerebral monoamines and hydroxyl radical production overload, and improves neuronal damage and the ST in rats. CONCLUSIONS: Our results suggest that the combination of a colloid substance with a volume-expanding effect and an anti-inflammatory agent may provide a better resuscitation solution for victims with heat stroke.
20937119	15	32	circulatory shock	Disease	MESH:D012769
20937119	37	61	cerebral ischemia injury	Disease	MESH:D002545
20937119	65	76	heat stroke	Disease	MESH:D018883
20937119	107	120	dexamethasone	Chemical	MESH:D003907
20937119	125	144	hydroxyethyl starch	Chemical	-
20937119	216	226	monoamines	Chemical	-
20937119	232	248	hydroxyl radical	Chemical	MESH:D017665
20937119	304	321	cerebral ischemia	Disease	MESH:D002545
20937119	326	341	neuronal damage	Disease	MESH:D009410
20937119	349	360	heat stroke	Disease	MESH:D018883
20937119	362	375	Dexamethasone	Chemical	MESH:D003907
20937119	377	380	DXM	Chemical	MESH:D003907
20937119	436	448	inflammation	Disease	MESH:D007249
20937119	454	473	hydroxyethyl starch	Chemical	-
20937119	475	478	HES	Chemical	-
20937119	518	535	cerebral ischemia	Disease	MESH:D002545
20937119	543	558	cerebral injury	Disease	MESH:D000070625
20937119	646	663	cerebral ischemia	Disease	MESH:D002545
20937119	745	748	HES	Chemical	-
20937119	753	756	DXM	Chemical	MESH:D003907
20937119	820	831	heat stroke	Disease	MESH:D018883
20937119	840	857	cerebral ischemia	Disease	MESH:D002545
20937119	862	877	neuronal damage	Disease	MESH:D009410
20937119	894	905	heat stroke	Disease	MESH:D018883
20937119	916	924	Urethane	Chemical	MESH:D014520
20937119	938	942	rats	Species	10116
20937119	1101	1116	neuronal damage	Disease	MESH:D009410
20937119	1128	1132	rats	Species	10116
20937119	1206	1217	heat stroke	Disease	MESH:D018883
20937119	1241	1260	ischemic and damage	Disease	MESH:D017202
20937119	1270	1278	dopamine	Chemical	MESH:D004298
20937119	1280	1289	serotonin	Chemical	MESH:D012701
20937119	1295	1311	hydroxyl radical	Chemical	MESH:D017665
20937119	1368	1386	interleukin-1 beta	Gene	24494
20937119	1388	1415	tumor necrosis factor-alpha	Gene	24835
20937119	1420	1435	malondialdehyde	Chemical	MESH:D008315
20937119	1437	1440	MDA	Chemical	MESH:D008315
20937119	1463	1474	heat stroke	Disease	MESH:D018883
20937119	1491	1502	heat stroke	Disease	MESH:D018883
20937119	1508	1512	rats	Species	10116
20937119	1523	1540	circulatory shock	Disease	MESH:D012769
20937119	1542	1562	arterial hypotension	Disease	MESH:D007022
20937119	1624	1627	MDA	Chemical	MESH:D008315
20937119	1657	1667	monoamines	Chemical	-
20937119	1672	1688	hydroxyl radical	Chemical	MESH:D017665
20937119	1721	1738	cerebral ischemia	Disease	MESH:D002545
20937119	1743	1758	neuronal damage	Disease	MESH:D009410
20937119	1803	1807	rats	Species	10116
20937119	1878	1889	heat stroke	Disease	MESH:D018883
20937119	1929	1940	heat stroke	Disease	MESH:D018883
20937119	1949	1966	circulatory shock	Disease	MESH:D012769
20937119	1977	1989	inflammation	Disease	MESH:D007249
20937119	1991	2008	cerebral ischemia	Disease	MESH:D002545
20937119	2019	2029	monoamines	Chemical	-
20937119	2034	2050	hydroxyl radical	Chemical	MESH:D017665
20937119	2085	2100	neuronal damage	Disease	MESH:D009410
20937119	2115	2119	rats	Species	10116
20937119	2241	2253	inflammatory	Disease	MESH:D007249
20937119	2321	2332	heat stroke	Disease	MESH:D018883
20937119	Association	MESH:D004298	MESH:D018883
20937119	Association	MESH:D018883	24494
20937119	Association	MESH:D004298	MESH:D017202
20937119	Positive_Correlation	MESH:D017665	MESH:D018883
20937119	Positive_Correlation	MESH:D017665	MESH:D002545
20937119	Negative_Correlation	MESH:D003907	MESH:D018883
20937119	Negative_Correlation	MESH:D003907	MESH:D009410
20937119	Positive_Correlation	MESH:D017665	MESH:D009410
20937119	Negative_Correlation	MESH:D003907	MESH:D002545
20937119	Negative_Correlation	MESH:D003907	MESH:D007249
20937119	Association	MESH:D012701	MESH:D018883
20937119	Association	MESH:D018883	24835
20937119	Positive_Correlation	MESH:D008315	MESH:D018883
20937119	Negative_Correlation	MESH:D003907	MESH:D012769

